Evaluating the risks and benefits of continuing versus withholding renin-angiotensin system inhibitors: a systematic review and meta-analysis with trial sequential analysis
{{output}}
Background: The best perioperative management of renin-angiotensin system inhibitors (RASi) in patients undergoing noncardiac surgery has been an ongoing debate as a result of inconclusive previous studies and insufficient data f... ...
